Merck KGaA Future Growth
Future criteria checks 1/6
Merck KGaA is forecast to grow earnings and revenue by 11.1% and 4.2% per annum respectively. EPS is expected to grow by 11.2% per annum. Return on equity is forecast to be 13% in 3 years.
Key information
11.1%
Earnings growth rate
11.2%
EPS growth rate
Pharmaceuticals earnings growth | 21.5% |
Revenue growth rate | 4.2% |
Future return on equity | 13.0% |
Analyst coverage | Good |
Last updated | 10 Dec 2024 |
Recent future growth updates
Recent updates
We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt
Dec 16Some Shareholders Feeling Restless Over Merck KGaA's (ETR:MRK) P/E Ratio
Oct 18Is There An Opportunity With Merck KGaA's (ETR:MRK) 44% Undervaluation?
Sep 05Here's Why Merck KGaA (ETR:MRK) Can Manage Its Debt Responsibly
Jul 24Some Confidence Is Lacking In Merck KGaA's (ETR:MRK) P/E
Jul 03Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 48% Above Its Share Price
May 22Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20
Apr 26Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20
Apr 04Merck KGaA (ETR:MRK) Has Affirmed Its Dividend Of €2.20
Mar 18We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt
Feb 07There's Reason For Concern Over Merck KGaA's (ETR:MRK) Price
Jan 17Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 23,070 | 3,716 | 3,748 | 5,620 | 14 |
12/31/2025 | 22,093 | 3,388 | 3,288 | 4,909 | 15 |
12/31/2024 | 21,150 | 2,936 | 3,011 | 5,378 | 15 |
9/30/2024 | 20,963 | 2,696 | 2,160 | 4,408 | N/A |
6/30/2024 | 20,870 | 2,626 | 2,052 | 4,205 | N/A |
3/31/2024 | 20,820 | 2,722 | 1,961 | 3,966 | N/A |
12/31/2023 | 20,993 | 2,824 | 1,897 | 3,784 | N/A |
9/30/2023 | 21,428 | 2,893 | 1,912 | 3,746 | N/A |
6/30/2023 | 22,061 | 3,078 | 2,198 | 4,042 | N/A |
3/31/2023 | 22,327 | 3,242 | 2,334 | 4,272 | N/A |
12/31/2022 | 22,232 | 3,326 | 2,491 | 4,259 | N/A |
9/30/2022 | 21,785 | 3,473 | 2,788 | 4,289 | N/A |
6/30/2022 | 20,952 | 3,311 | 2,658 | 4,204 | N/A |
3/31/2022 | 20,254 | 3,188 | 2,734 | 4,240 | N/A |
12/31/2021 | 19,687 | 3,055 | 3,234 | 4,616 | N/A |
9/30/2021 | 19,072 | 2,689 | 3,125 | 4,859 | N/A |
6/30/2021 | 18,546 | 2,733 | 3,073 | 4,562 | N/A |
3/31/2021 | 17,795 | 2,278 | 2,702 | 4,177 | N/A |
12/31/2020 | 17,534 | 1,987 | 2,002 | 3,477 | N/A |
9/30/2020 | 17,317 | 1,884 | 1,684 | 2,879 | N/A |
6/30/2020 | 16,924 | 1,419 | 1,498 | 2,640 | N/A |
3/31/2020 | 16,776 | 1,549 | 1,729 | 2,879 | N/A |
12/31/2019 | 16,152 | 1,292 | 1,858 | 2,856 | N/A |
9/30/2019 | 15,658 | 1,139 | 1,967 | 2,906 | N/A |
6/30/2019 | 15,354 | 1,118 | 1,751 | 2,706 | N/A |
3/31/2019 | 15,096 | 938 | 1,425 | 2,332 | N/A |
12/31/2018 | 14,836 | 1,071 | 1,270 | 2,219 | N/A |
9/30/2018 | 14,597 | 1,921 | 1,031 | 2,120 | N/A |
6/30/2018 | 14,364 | 2,218 | N/A | 2,147 | N/A |
3/31/2018 | 14,346 | 2,389 | N/A | 2,299 | N/A |
12/31/2017 | 14,517 | 2,548 | N/A | 2,696 | N/A |
9/30/2017 | 14,699 | 1,787 | N/A | 2,842 | N/A |
6/30/2017 | 14,906 | 1,628 | N/A | 3,152 | N/A |
3/31/2017 | 15,016 | 1,529 | N/A | 2,943 | N/A |
12/31/2016 | 15,024 | 1,629 | N/A | 2,518 | N/A |
9/30/2016 | 14,658 | 1,480 | N/A | 2,449 | N/A |
6/30/2016 | 14,054 | 1,387 | N/A | 2,253 | N/A |
3/31/2016 | 13,469 | 1,418 | N/A | 2,268 | N/A |
12/31/2015 | 12,845 | 1,109 | N/A | 2,195 | N/A |
9/30/2015 | 12,380 | 1,269 | N/A | 2,618 | N/A |
6/30/2015 | 12,180 | 1,154 | N/A | 2,472 | N/A |
3/31/2015 | 11,776 | 1,114 | N/A | 2,576 | N/A |
12/31/2014 | 11,363 | 1,157 | N/A | 2,706 | N/A |
9/30/2014 | 11,106 | 1,158 | N/A | 2,005 | N/A |
6/30/2014 | 10,937 | 1,249 | N/A | 2,105 | N/A |
3/31/2014 | 10,963 | 1,261 | N/A | 2,119 | N/A |
12/31/2013 | 11,095 | 1,202 | N/A | 2,226 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MRK's forecast earnings growth (11.1% per year) is above the savings rate (1%).
Earnings vs Market: MRK's earnings (11.1% per year) are forecast to grow slower than the German market (20.6% per year).
High Growth Earnings: MRK's earnings are forecast to grow, but not significantly.
Revenue vs Market: MRK's revenue (4.2% per year) is forecast to grow slower than the German market (5.7% per year).
High Growth Revenue: MRK's revenue (4.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MRK's Return on Equity is forecast to be low in 3 years time (13%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 09:22 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Merck KGaA is covered by 61 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Martin Schnee | AlphaValue |
Gerhard Schwarz | Baader Helvea Equity Research |
Odile Rundquist | Baader Helvea Equity Research |